Table 3.

Dexmedetomidine administration

	Group 1 (n = 13)	Group 2 (n = 29)	Group 3 (n = 8)	Group 4 (n = 10)	Group 5 (n = 2)
Duration, days	5.9 (4.1–13.5)	6.3 (4–19)	5 (4.6–19.7)	4.8 (4–26.2)	4.5 (4.2–4.9)
Mean infusion dose, μg/kg/h	0.7 (0.4–1.3)	0.7 (0.3–2.1)	0.9 (0.2–1.2)	0.7 (0.3–1.1)	0.33 (0.2–0.5)
Infusion dose at discontinuation, μg/kg/h	0.2 (0.1–1.3)	0.2 (0.1–1.1)	0.9 (0.1–1.1)	0.2 (0.1–0.8)	0.3 (0.2–0.5)
Weaning time, hours	49 (0–91)	44 (0–169)	54 (0–116)	51 (0–151)	50 (32–69)

Data are expressed as medians and range.